HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

R 1507

human insulin-like growth factor-I receptor antagonist in phase I clinical trials (2010)
Also Known As:
R-1507; R1507
Networked: 17 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Heskamp, Sandra: 5 articles (09/2013 - 10/2010)
2. van Laarhoven, Hanneke W M: 5 articles (09/2013 - 10/2010)
3. Molkenboer-Kuenen, Janneke D M: 5 articles (09/2013 - 10/2010)
4. Oyen, Wim J G: 5 articles (09/2013 - 10/2010)
5. van der Graaf, Winette T A: 5 articles (09/2013 - 10/2010)
6. Boerman, Otto C: 5 articles (09/2013 - 10/2010)
7. Helman, Lee J: 3 articles (04/2015 - 12/2011)
8. Versleijen-Jonkers, Yvonne M H: 3 articles (09/2013 - 10/2010)
9. Maki, Robert G: 2 articles (08/2014 - 12/2011)
10. Schuetze, Scott M: 2 articles (08/2014 - 12/2011)

Related Diseases

1. Neoplasms (Cancer)
2. Osteosarcoma (Osteogenic Sarcoma)
3. Sarcoma (Soft Tissue Sarcoma)
4. Rhabdomyosarcoma
5. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

Related Drugs and Biologics

1. Sirolimus (Rapamycin)
2. Insulin (Novolin)
3. IGF Type 1 Receptor (IGF 1 Receptor)
4. erlotinib (CP 358,774)
5. Immunoglobulin G (IgG)
6. Small Interfering RNA (siRNA)
7. Biological Markers (Surrogate Marker)
8. Protein-Tyrosine Kinases (Tyrosine Kinase)
9. Phosphotransferases (Kinase)
10. Metformin (Glucophage)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Aftercare (After-Treatment)